English

HEMAGEN DIAGNOSTICS INC

EDGAR

Annual report (10-K) · filed 2012-12-28

74 filing records in this dataset, filed from 1996-05-23 to 2012-12-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

876 thousand USD

2012 Q4 · USD

Exact inputs and evidence

Revenue: 4042094 USD Source
Revenue: 3166182 USD Source

Operating margin

-4.99%

2012 Q4 · %

Exact inputs and evidence

Operating Income: -437914 USD Source
Operating Income: -394209 USD Source
Revenue: 4042094 USD Source
Revenue: 3166182 USD Source

Operating cash flow

-50.8 thousand USD

2012 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -358687 USD Source
Operating Cash Flow: -307849 USD Source

Cash and cash equivalents: 66.3 thousand USD 2012-09-30 Source
Exact value

66287 USD
Long-term debt including current maturities: Not available
Shares outstanding: 15.6 million shares 2012-09-30 Source
Exact value

15600281 shares

Reported share-count change

0.10% · 15 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

15585281 shares · 2011-09-30· Source
15600281 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.04 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Revenue: 1107074 USD · 2011-10-01 – 2011-12-31 Source
Revenue: 1111301 USD · 2012-01-01 – 2012-03-31 Source
Revenue: 947807 USD · 2012-04-01 – 2012-06-30 Source
Revenue: 4042094 USD · 2011-10-01 – 2012-09-30 Source
Revenue: 3166182 USD · 2011-10-01 – 2012-06-30 Source

Net income

-907 thousand USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Net income: -368559 USD · 2011-10-01 – 2011-12-31 Source
Net income: -243642 USD · 2012-01-01 – 2012-03-31 Source
Net income: -132132 USD · 2012-04-01 – 2012-06-30 Source
Net income: -907315 USD · 2011-10-01 – 2012-09-30 Source
Net income: -744332 USD · 2011-10-01 – 2012-06-30 Source

Operating cash flow

-359 thousand USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: -208187 USD · 2011-10-01 – 2011-12-31 Source
Operating cash flow: -324865 USD · 2011-10-01 – 2012-03-31 Source
Operating cash flow: -208187 USD · 2011-10-01 – 2011-12-31 Source
Operating cash flow: -307849 USD · 2011-10-01 – 2012-06-30 Source
Operating cash flow: -324865 USD · 2011-10-01 – 2012-03-31 Source
Operating cash flow: -358687 USD · 2011-10-01 – 2012-09-30 Source
Operating cash flow: -307849 USD · 2011-10-01 – 2012-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-12-28.

Financial data available through: 2012-09-30.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2012-09-30
Operating income: 4 of 11 periods available· newest 2012-09-30
Net income: 4 of 11 periods available· newest 2012-09-30
Operating cash flow: 3 of 11 periods available· newest 2012-09-30
Capital expenditure: 2 of 11 periods available· newest 2011-09-30
Total assets: 4 of 11 periods available· newest 2012-09-30
Total liabilities: 4 of 11 periods available· newest 2012-09-30
Current assets: 4 of 11 periods available· newest 2012-09-30
Current liabilities: 4 of 11 periods available· newest 2012-09-30
Cash and cash equivalents: 4 of 11 periods available· newest 2012-09-30
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2012-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-21.4%

Prior period

USD 5.14 million

2010-10-01 – 2011-09-30
Current period

USD 4.04 million

2011-10-01 – 2012-09-30

Exact inputs and evidence

4042094 − 5141226 = -1099132 USD

5141226 USD · 2010-10-01 – 2011-09-30
Inspect prior input Prior source
4042094 USD · 2011-10-01 – 2012-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · HEMAGEN DIAGNOSTICS INC · 2012-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Year-over-year change in Revenue: -1099132 USD Concept: fundies:Revenue Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4042094 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#15160 Filing: 000144586612001120 Input fundies:Revenue: 5141226 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#15043 Filing: 000144586612001120
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 26,839

Prior period

−USD 880,476

2010-10-01 – 2011-09-30
Current period

−USD 907,315

2011-10-01 – 2012-09-30

Exact inputs and evidence

-907315 − -880476 = -26839 USD

-880476 USD · 2010-10-01 – 2011-09-30
Inspect prior input Prior source
-907315 USD · 2011-10-01 – 2012-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · HEMAGEN DIAGNOSTICS INC · 2012-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Year-over-year change in Net income: -26839 USD Concept: fundies:NetIncome Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -907315 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14930 Filing: 000144586612001120 Input fundies:NetIncome: -880476 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14534 Filing: 000144586612001120
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 21,519

Prior period

−USD 337,168

2010-10-01 – 2011-09-30
Current period

−USD 358,687

2011-10-01 – 2012-09-30

Exact inputs and evidence

-358687 − -337168 = -21519 USD

-337168 USD · 2010-10-01 – 2011-09-30
Inspect prior input Prior source
-358687 USD · 2011-10-01 – 2012-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · HEMAGEN DIAGNOSTICS INC · 2012-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Year-over-year change in Operating cash flow: -21519 USD Concept: fundies:OperatingCashFlow Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -358687 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14080 Filing: 000144586612001120 Input fundies:OperatingCashFlow: -337168 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#13909 Filing: 000144586612001120
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2011-10-01 – 2012-09-30

Revenue USD 4.04 million 100% of revenue
Cost of revenue USD 2.43 million 60% of revenue
Operating expenses USD 2.05 million 51% of revenue
Operating income −USD 437,914 −11% of revenue
Tax, interest and other Derived USD 469,401 12% of revenue
Net income −USD 907,315 −22% of revenue

Cash

Operating cash flow −USD 358,687 −8.9% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 107% of revenue.
2010 Net loss: net income was −3% of revenue.
2011 Operating loss: operating costs were 109% of revenue.
2012 Operating loss: operating costs were 111% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2001-10-01 – 2002-09-30	9499532	10170620 Derived	-671088	1089395 Derived	-1760483	Unavailable	Source 2001-10-01 – 2002-09-30: 9499532 USD Inspect Revenue Open source 2001-10-01 – 2002-09-30: -671088 USD Inspect Operating Income Open source 2001-10-01 – 2002-09-30: -1760483 USD Inspect Net Income Open source
2010 2009-10-01 – 2010-09-30	5220170	4984224 Derived	235946	392260 Derived	-156314	Unavailable	Source 2009-10-01 – 2010-09-30: 5220170 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: 235946 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: -156314 USD Inspect Net Income Open source 2009-10-01 – 2010-09-30: -183179 USD Inspect Operating Cash Flow Open source 2009-10-01 – 2010-09-30: -74142 USD Inspect Capital Expenditure Open source
2011 2010-10-01 – 2011-09-30	5141226	5613943 Derived	-472717	407759 Derived	-880476	Unavailable	Source 2010-10-01 – 2011-09-30: 5141226 USD Inspect Revenue Open source 2010-10-01 – 2011-09-30: -472717 USD Inspect Operating Income Open source 2010-10-01 – 2011-09-30: -880476 USD Inspect Net Income Open source 2010-10-01 – 2011-09-30: -337168 USD Inspect Operating Cash Flow Open source 2010-10-01 – 2011-09-30: -56414 USD Inspect Capital Expenditure Open source
2012 2011-10-01 – 2012-09-30	4042094	4480008 Derived	-437914	469401 Derived	-907315	Unavailable	Source 2011-10-01 – 2012-09-30: 4042094 USD Inspect Revenue Open source 2011-10-01 – 2012-09-30: -437914 USD Inspect Operating Income Open source 2011-10-01 – 2012-09-30: -907315 USD Inspect Net Income Open source 2011-10-01 – 2012-09-30: -358687 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4M 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Revenue	9499532	Revenue: 9499532 Open source
20102010-09-30	Revenue	5220170	Revenue: 5220170 Open source
20112011-09-30	Revenue	5141226	Revenue: 5141226 Open source
20122012-09-30	Revenue	4042094	Revenue: 4042094 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-21.4% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Year over year	No prior comparable period	Revenue: 9499532 Open source
20102010-09-30	Year over year	No prior comparable period	Revenue: 5220170 Open source
20112011-09-30	Year over year	-1.5%	Revenue: 5141226 Open source Revenue: 5220170 Open source
20122012-09-30	Year over year	-21.4%	Revenue: 4042094 Open source Revenue: 5141226 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -10.8% 2012

Net margin -22.4% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Operating margin	-7.1%	Operating Income: -671088 Open source Revenue: 9499532 Open source
20102010-09-30	Operating margin	4.5%	Operating Income: 235946 Open source Revenue: 5220170 Open source
20112011-09-30	Operating margin	-9.2%	Operating Income: -472717 Open source Revenue: 5141226 Open source
20122012-09-30	Operating margin	-10.8%	Operating Income: -437914 Open source Revenue: 4042094 Open source
20022002-09-30	Net margin	-18.5%	Net Income: -1760483 Open source Revenue: 9499532 Open source
20102010-09-30	Net margin	-3%	Net Income: -156314 Open source Revenue: 5220170 Open source
20112011-09-30	Net margin	-17.1%	Net Income: -880476 Open source Revenue: 5141226 Open source
20122012-09-30	Net margin	-22.4%	Net Income: -907315 Open source Revenue: 4042094 Open source
20022002-09-30	Free cash flow margin	Not reported	Revenue: 9499532 Open source
20102010-09-30	Free cash flow margin	Not reported	Revenue: 5220170 Open source Operating Cash Flow: -183179 Open source Capital Expenditure: -74142 Open source
20112011-09-30	Free cash flow margin	Not reported	Revenue: 5141226 Open source Operating Cash Flow: -337168 Open source Capital Expenditure: -56414 Open source
20122012-09-30	Free cash flow margin	Not reported	Revenue: 4042094 Open source Operating Cash Flow: -358687 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -358.7K 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Operating cash flow	Not reported	No source recorded
20102010-09-30	Operating cash flow	-183179	Operating Cash Flow: -183179 Open source
20112011-09-30	Operating cash flow	-337168	Operating Cash Flow: -337168 Open source
20122012-09-30	Operating cash flow	-358687	Operating Cash Flow: -358687 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-09-30	Free cash flow	Unavailable	No source recorded
20102010-09-30	Free cash flow	Unavailable	Operating Cash Flow: -183179 Open source Capital Expenditure: -74142 Open source
20112011-09-30	Free cash flow	Unavailable	Operating Cash Flow: -337168 Open source Capital Expenditure: -56414 Open source
20122012-09-30	Free cash flow	Unavailable	Operating Cash Flow: -358687 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

245.6% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Liabilities / assets	54.4%	Total Liabilities: 3816598 Open source Total Assets: 7022228 Open source
20102010-09-30	Liabilities / assets	154.8%	Total Liabilities: 5218365 Open source Total Assets: 3371394 Open source
20112011-09-30	Liabilities / assets	193%	Total Liabilities: 5575372 Open source Total Assets: 2888302 Open source
20122012-09-30	Liabilities / assets	245.6%	Total Liabilities: 5999545 Open source Total Assets: 2442744 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.07× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-09-30	Current assets / current liabilities	3.05×	Current Assets: 5192073 Open source Current Liabilities: 1700649 Open source
20102010-09-30	Current assets / current liabilities	2.37×	Current Assets: 2770486 Open source Current Liabilities: 1168507 Open source
20112011-09-30	Current assets / current liabilities	1.61×	Current Assets: 2449124 Open source Current Liabilities: 1525514 Open source
20122012-09-30	Current assets / current liabilities	1.07×	Current Assets: 2094746 Open source Current Liabilities: 1949687 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-10-01 – 2002-09-30	−USD 1.76 million Exact value Exact value: -1760483 USD 2001-10-01 – 2002-09-30: -1760483 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMAGEN DIAGNOSTICS INC · 2002-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Net Income: -1760483 USD Concept: fundies:NetIncome Period: 2001-10-01 to 2002-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3ANetIncome&period=2002-09-30&surface=latest&period_type=duration&start=2001-10-01&unit=USD&dimensions= Input fundies:NetIncome: -1760483 USD (2001-10-01 to 2002-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/0000950152-02-009611.txt#1612 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2009-10-01 – 2010-09-30	−USD 156,314 Exact value Exact value: -156314 USD 2009-10-01 – 2010-09-30: -156314 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMAGEN DIAGNOSTICS INC · 2010-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Net Income: -156314 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: -156314 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586611000164/hmgn-20110930.xml#15231 Filing: 000144586611000164 The citation records this snapshot. The page link may show a newer release later.	−USD 183,179 Exact value Exact value: -183179 USD 2009-10-01 – 2010-09-30: -183179 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMAGEN DIAGNOSTICS INC · 2010-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Operating Cash Flow: -183179 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3AOperatingCashFlow&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -183179 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586611000164/hmgn-20110930.xml#21203 Filing: 000144586611000164 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.
2011 2010-10-01 – 2011-09-30	−USD 880,476 Exact value Exact value: -880476 USD 2010-10-01 – 2011-09-30: -880476 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMAGEN DIAGNOSTICS INC · 2011-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Net Income: -880476 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: -880476 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14534 Filing: 000144586612001120 The citation records this snapshot. The page link may show a newer release later.	−USD 337,168 Exact value Exact value: -337168 USD 2010-10-01 – 2011-09-30: -337168 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMAGEN DIAGNOSTICS INC · 2011-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Operating Cash Flow: -337168 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3AOperatingCashFlow&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -337168 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#13909 Filing: 000144586612001120 The citation records this snapshot. The page link may show a newer release later.	Unavailable The mapped spending value is negative, so its direction is unclear. Source Inspect Capital Expenditure Open source	Unavailable Capital expenditure has a negative mapped value; spending direction is unclear.
2012 2011-10-01 – 2012-09-30	−USD 907,315 Exact value Exact value: -907315 USD 2011-10-01 – 2012-09-30: -907315 USD Inspect Net Income Open source Share or cite Citation for Net Income · HEMAGEN DIAGNOSTICS INC · 2012-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Net Income: -907315 USD Concept: fundies:NetIncome Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3ANetIncome&period=2012-09-30&surface=latest&period_type=duration&start=2011-10-01&unit=USD&dimensions= Input fundies:NetIncome: -907315 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14930 Filing: 000144586612001120 The citation records this snapshot. The page link may show a newer release later.	−USD 358,687 Exact value Exact value: -358687 USD 2011-10-01 – 2012-09-30: -358687 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · HEMAGEN DIAGNOSTICS INC · 2012-09-30 HEMAGEN DIAGNOSTICS INC (edgar:892822) Operating Cash Flow: -358687 USD Concept: fundies:OperatingCashFlow Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T02:57:35Z Snapshot: 059bad47cd31e3d79487b64de3fe8d92c40eb737e043f1f37ddcbfdfc15d1099 Dimensions: Consolidated View: https://fundies.io/companies/edgar/892822/explain?concept=fundies%3AOperatingCashFlow&period=2012-09-30&surface=latest&period_type=duration&start=2011-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -358687 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/892822/000144586612001120/hmgn-20120930.xml#14080 Filing: 000144586612001120 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

74 filings · 679 latest values · 679 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000892822, 892822, edgar:892822

Also known as HEMAGEN DIAGNOSTICS INC

HEMAGEN DIAGNOSTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2012 2011-10-01 – 2012-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation